Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

<< Previous
Bullboard Posts
Next >>
Post by Stockfshron May 18, 2022 3:06pm
171 Views
Post# 34693236

Per Lukethetrader at ceo.ca sva board

Per Lukethetrader at ceo.ca sva board Source: Smallcapstockpickingcanada

Currently, Evotec's small shareholders are pissed because Sernova is not a Big Pharma company and there is ZERO dollar upfront payment. Sernova's small shareholders are pissed because the partner is not a very big pharma company and there are no triple-digit upfront payments to Sernova other than the 20m euro investment. The fact that the combination creates a solution that could generate high triple-digit million sales in a few years and billions within a few years after market launch is probably understood by very few. Evotec may even tailor iPSC cells for other indications from Sernova in the future. I think that some companies have been forced into action after yesterday's news. There will be no further partner in the diabetes area. Those who urgently need Sernova's Cell Pouch System can already start calculating a possible takeover valuation or can cancel projects. The heat is on. There will be a bidding war for Sernova - hopefully not too early.
 
<< Previous
Bullboard Posts
Next >>